期刊
EUROPEAN JOURNAL OF PHARMACOLOGY
卷 674, 期 2-3, 页码 73-79出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejphar.2011.10.015
关键词
SIRT1; Resveratrol; Inducible nitric oxide synthase; Nuclear factor-kappa B; Articular chondrocytes
资金
- Shenzhen Bureau of Science Technology Information [SG200810200101A, SG200810200102A]
- National Natural Science Foundation of China [81101383]
In chondrocytes, resveratrol, a natural SIRT1 activator, exerts an anti-inflammatory response via inhibition of nuclear factor kappaB (NF-kappa B). Given that SIRT1 inhibits the transactivation potential of NF-kappa B by deacetylating acetylated lysines in p65, the NF-kappa B subunit, we investigated the effects of resveratrol-activated SIRT1 on articular chondrocytes. We found that when chondrocytes were stimulated with interleukin 1 beta (IL-1 beta), the time- and dose-dependent expression of inducible nitric oxide synthase (iNOS) expression and nitric oxide (NO) production was suppressed by resveratrol. Resveratrol-activated SIRT1 mediated this suppression. SIRT1 suppressed not only the nuclear translocation of NF-kappa B but also the acetylation of p65. Furthermore, acetylated Lys310 in p65, which must be present for transactivation activity, was the immediate downstream target of SIRT1. Therefore, SIRT1 protects against the inflammatory response induced by IL-1 beta in articular chondrocytes. Resveratrol, as an activator of SIRT1, merits consideration as a therapeutic agent in the treatment and prevention of osteoarthritis. (C) 2011 Published by Elsevier B.V.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据